Beginning Cash: The amount of cash reported by the company on its previous statement.
Arcturus Therapeutics Holdings Inc. (ARCT) had Beginning Cash of $293.91M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$7.20M |
|
$-29.08M |
|
-- |
|
$7.20M |
|
$38.50M |
|
$-31.31M |
|
$2.22M |
|
$-29.08M |
|
$-29.08M |
|
$-29.08M |
|
$-29.08M |
|
$-29.08M |
|
$-29.08M |
|
$-31.31M |
|
$-30.62M |
|
27.39M |
|
27.39M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$241.45M |
|
$6.74M |
|
$29.70M |
|
$271.15M |
|
$36.38M |
|
-- |
|
$20.78M |
|
$57.16M |
|
$213.99M |
|
$213.99M |
|
$213.99M |
|
28.41M |
|
| Cash Flow Statement Financials | |
$-74.27M |
|
$-0.23M |
|
$13.38M |
|
|
Beginning Cash |
$293.91M |
$232.79M |
|
$-61.12M |
|
$25.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-434.99% |
|
-434.99% |
|
-- |
|
-404.10% |
|
-404.04% |
|
$-74.50M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.29 |
|
69.58 |
|
-13.59% |
|
-13.59% |
|
-10.72% |
|
-13.59% |
|
$7.53 |
|
$-2.72 |
|
$-2.71 |
|